SCHEMBL7790003

SCHEMBL7790003

CCCN(CCC)c1ccc(Cl)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 5/20 0.46
EGFR P00533 2/20 0.44
ERBB2 P04626 2/20 0.44
CRHR1 P34998 4/20 0.41
CNR1 P21554 1/20 0.40
LMNA P02545 1/20 0.38
CYP2A6 P11509 1/20 0.38
MAPT P10636 1/20 0.38
PSMD14 O00487 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP3A4 P08684 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
RECQL P46063 1/20 0.38
GFER P55789 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KCNH2 Q12809 2/20 0.38
ALDH3A1 P30838 1/20 0.38
ALDH1A3 P47895 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15850059 0.90 CNR2 (0.40) CNR2EGFRERBB2CRHR1CNR1
SCHEMBL7150414 0.87 EGFR (0.47) CNR2EGFRERBB2MAPTPSMD14
SCHEMBL16503375 0.87 CNR2 (0.38) CNR2EGFRERBB2CRHR1CNR1
SCHEMBL6565246 0.86 EGFR (0.47) CNR2EGFRERBB2KCNH2
SCHEMBL23762214 0.85 EGFR (0.54) CNR2EGFRERBB2LMNAMAPT
SCHEMBL28598991 0.83 CNR2 (0.54) CNR2EGFRERBB2KCNH2
SCHEMBL4224314 0.82 EGFR (0.44) CNR2EGFRERBB2MAPTPSMD14
SCHEMBL3349327 0.81 CNR2 (0.43) CNR2EGFRERBB2CNR1MAPT
SCHEMBL10300283 0.80 HRH3 (0.48) CNR2EGFRERBB2MAPTPSMD14
SCHEMBL7155728 0.80 HRH3 (0.48) CNR2EGFRERBB2MAPTPSMD14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1150963-A1 SUBSTITUTED 4-AMINO-2-ARYLTETRAHYDROQUINAZOLINES, THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM Aventis Pharma Deutschland GmbH (DE) 2001-11-07 EP disclosed
WO-2000046214-A1 SUBSTITUTED 4-AMINO-2-ARYLTETRAHYDROQUINAZOLINES, THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-08-10 WO disclosed